Advancing Knowledge,
Improving Patient Outcomes

AcademicCME is a jointly accredited healthcare solutions medical education company designed to impact practice behavior by providing clinicians with multi-format educational resources in various therapeutic areas. Our mission is to improve patient outcomes through practical, customized and comprehensive continuing education.

CE Courses

Update on New and Emerging CD-20 Targeted Therapeutics for the Treatment of Patients with Multiple Sclerosis

Program Overview

This CME program, derived from content presented at the Pre-ACTRIMS Advanced Curriculum for Multiple Sclerosis 2023 CME Course in San Diego, California, will highlight new and emerging CD-20 targeted therapeutics for the treatment of patients with multiple sclerosis (MS). The expert faculty, Dr. Mark Freedman, will first review current clinical trial data for CD-20 targeted therapies to improve ...
View Course

Accurate and Effective Imaging in the Diagnosis and Management of Hypertrophic Cardiomyopathy: A Practical Approach

Program Overview

Accurate diagnosis is vital for the successful management of patients with HCM.  Mistakes and delays in diagnosis are common. Hypertrophic cardiomyopathy commonly "masquerades" as asthma, anxiety, mitral prolapse, and coronary artery disease. However, once properly diagnosed, patients with HCM can be effectively managed to improve both symptoms and survival. Today, the diagnosis of HCM relies on the identification ...
View Course
Anti-CD19 Therapeutics to Manage Patients with Anti-AQP4 Antibody Positive Neuromyelitis Optics Spectrum Disorder

Program Overview

This CME program, derived from content presented at the Pre-ACTRIMS Advanced Curriculum for Multiple Sclerosis 2023 CME Course in San Diego, California, will highlight the use of anti-CD19 therapeutics to manage patients with anti-AQP4 antibody positive neuromyelitis optica spectrum disorder (NMOSD). The expert faculty, Prof. Hans-Peter Hartung, will first analyze the methodologies for a timely and accurate diagnosis ...
View Course

Advances in the Management of Patients with Diabetic Kidney Disease in the Setting of Type 2 Diabetes

Program Overview

New, actionable data on the use of sodium-glucose co-transporter-2 (SGLT2) inhibitors was released at several major meetings in 2022, culminating in November at ASN/Kidney Week that herald signal advances in the management of DKD/T2D. These new data and an expert contextualization of their role in contemporary practice is the basis of this webcast.

Target Audience

Nephrologists, diabetologists, other ...
View Course
Specific Reversal of Anti-Factor Xa DOAC Anticoagulation: Incorporating Latest Data into Practice and Institutional Protocols

Program Overview

Severe and life-threatening hemorrhage in patients receiving anti-FXa DOACs is unusual; especially for the most-feared bleeding complication, ICH, events are significantly less common than for patients on vitamin K antagonists (VKA).  Still, these events occur, and there is a need for specific, timely, evidence-guided, and multimodal management of DOAC-treated patients with hemorrhage to avoid worsening morbidity, excessive cost ...
View Course
Utilizing Immunohistochemistry Testing, Biomarkers, and Targeted Therapeutics to Optimize Outcomes in Patients with NSCLC

Program Overview

This CME program, derived from content presented at the ESMO Immuno-Oncology Congress 2022 in Geneva, Switzerland, will highlight the utilization of immunohistochemistry testing, biomarkers, and targeted therapeutics to optimize outcomes in patients with non-small cell lung cancer (NSCLC). The expert faculty, led by Dr. Solange Peters, will first review the scientific advances for the identification of NSCLC biomarkers, ...
View Course

Upcoming Events

Advanced Curriculum for Multiple Sclerosis 2024

February 27th, 2024

ACTRIMS Forum 2024

February 29th – March 2nd, 2024

Georgia Neurological Society Annual Meeting

March 22nd – 23rd, 2024

San Francisco Neurological Society Annual Meeting

March 22nd – 24th, 2024

Leave a Reply

Your email address will not be published. Required fields are marked *